Mirae Asset Global ETFs Holdings
LYEL icon

Mirae Asset Global ETFs Holdings’s Lyell Immunopharma LYEL Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14,782
Closed -$159K – 3144
2025
Q1 		$159K Sell
14,782
-646
-4% -$7.91K ﹤0.01% 2424
2024
Q4 		$197K Buy
15,428
+1,828
+13% +$36.2K ﹤0.01% 2392
2024
Q3 		$375K Sell
13,600
-2,020
-13% -$59.4K ﹤0.01% 2060
2024
Q2 		$453K Buy
+15,620
New +$744K ﹤0.01% 1869

Other funds holding LYEL

AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $267M AUM 5.05% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's LYEL Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of Lyell Immunopharma (LYEL) in Q2 2025, closing a stake of 14,782 shares — an estimated $159K sold.

Mirae Asset Global ETFs Holdings first reported a position in LYEL in Q2 2024 and held it in 4 quarters. The position peaked at $453K in Q2 2024. 69 funds tracked by Wall St. Rank hold LYEL as of Q2 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining Lyell Immunopharma position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 14,782 Lyell Immunopharma shares in Q2 2025, an estimated $159K.
  • Mirae Asset Global ETFs Holdings first reported a position in Lyell Immunopharma in Q2 2024 and held it in 4 quarters.
  • Mirae Asset Global ETFs Holdings's Lyell Immunopharma position peaked at $453K in Q2 2024.
  • 69 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.